Synergistic Stack #2: Injury Recovery & Healing For accelerated healing of muscle, tendon, or joint injuries: IGF-1 LR3: 30 mcg once daily for 4 weeks BPC-157: 250 mcg 2x/day for 4-6 weeks (use our BPC-157 calculator) TB-500: 5 mg 2x/week for 4-6 weeks Synergy: IGF-1 LR3 promotes muscle cell growth, BPC-157 supports vascular and epithelial healing, TB-500 enhances cellular migration and tissue repair
Patients with a history of thyroid eye disease should be monitored closely for any worsening of ocular symptoms, though there is no established link between tirzepatide and ophthalmopathy progression
Presented for research literature review only Bar-Joseph H et al
Research Applications & Usage Information PT-141 (10 mg) is commonly used in laboratory research for: Melanocortin receptor (MC3R/MC4R) binding assays Neuroendocrine pathway analysis Peptidereceptor interaction studies Central nervous system signaling models Comparative evaluation of melanocortin analog peptides In vitro and preclinical studies assessing receptor-mediated signaling Applications are strictly investigational and conducted within controlled laboratory environments
It inhibits the enzyme tyrosinase, which is involved in melanin production
Furthermore, there is ongoing research on whether Rybelsus can be used to treat certain types of cancer